Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Miyata

Showing results (231-240 of 249) with videos related to

Pageof 25
Sort By:
The Journal of Biological Chemistry|August 12, 1994
Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reactionH Yamada, S Miyata, N Igaki, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetesH Odani, K Iijima, M Nakata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
The role of renal dopamine in the reduction of high blood pressure by beta 1-selective beta-blocker with intrinsic sympathomimetic activity in spontaneously hypertensive ratsT Haneda, K Okamoto, T Hiroshima, et al.
Cell and Tissue Research|June 1, 1997
Immunochemical demonstration of Eisenia tetradecapeptide, a bioactive peptide isolated from the gut of the earthworm Eisenia foetida, in tissues of the earthwormK Ukena, T Oumi, F Morishita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1989
[Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies]I Tanaka, A Yoshioka, M Shima, et al.
Thrombosis and Haemostasis|October 6, 1997
A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotypeA B Federici, P M Mannucci, F Stabile, et al.
Thrombosis and Haemostasis|October 5, 1992
The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor bindingY Fujimura, S Miyata, S Nishida, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical studyM Nakashima, T Nakano, Y Ametani, et al.
Calcified Tissue International|April 23, 2011
Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in miceTulasi Ponnapakkam, R Katikaneni, E Miller, et al.
Vox Sanguinis|May 30, 2009
Consecutive national surveys of ABO-incompatible blood transfusion in JapanY Fujii, Y Shibata, S Miyata, et al.
Pageof 25

Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
The Journal of Biological Chemistry|August 12, 1994
Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reactionH Yamada, S Miyata, N Igaki, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetesH Odani, K Iijima, M Nakata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
The role of renal dopamine in the reduction of high blood pressure by beta 1-selective beta-blocker with intrinsic sympathomimetic activity in spontaneously hypertensive ratsT Haneda, K Okamoto, T Hiroshima, et al.
Cell and Tissue Research|June 1, 1997
Immunochemical demonstration of Eisenia tetradecapeptide, a bioactive peptide isolated from the gut of the earthworm Eisenia foetida, in tissues of the earthwormK Ukena, T Oumi, F Morishita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1989
[Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies]I Tanaka, A Yoshioka, M Shima, et al.
Thrombosis and Haemostasis|October 6, 1997
A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotypeA B Federici, P M Mannucci, F Stabile, et al.
Thrombosis and Haemostasis|October 5, 1992
The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor bindingY Fujimura, S Miyata, S Nishida, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical studyM Nakashima, T Nakano, Y Ametani, et al.
Calcified Tissue International|April 23, 2011
Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in miceTulasi Ponnapakkam, R Katikaneni, E Miller, et al.
Vox Sanguinis|May 30, 2009
Consecutive national surveys of ABO-incompatible blood transfusion in JapanY Fujii, Y Shibata, S Miyata, et al.
Pageof 25